ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20
Showing 1 - 25 of >10,000
Ankylosing Spondylitis Trial in Worldwide (Secukinumab, GP2017 (adalimumab biosimilar))
Completed
- Ankylosing Spondylitis
- Secukinumab
- GP2017 (adalimumab biosimilar)
-
Mesa, Arizona
- +169 more
Sep 9, 2022
Ankylosing Spondylitis Trial in United States (150 mg open-label secukinumab, 150 mg double-blinded secukinumab, 300 mg
Completed
- Ankylosing Spondylitis
- 150 mg open-label secukinumab
- +2 more
-
Jonesboro, Arkansas
- +64 more
Apr 27, 2022
Ankylosing Spondylitis, Axial Spondyloarthritis Trial (Adalimumab and its biosimilars, Biological: Etanercept and its
Not yet recruiting
- Ankylosing Spondylitis
- Axial Spondyloarthritis
- Adalimumab and its biosimilars
- +3 more
- (no location specified)
Dec 6, 2021
Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)
Not yet recruiting
- Non-radiographic Axial Spondyloarthritis
- Secukinumab
- Placebo
- (no location specified)
Nov 16, 2022
Adalimumab on Health Outcomes in Chinese Immune-Mediated
Completed
- Ankylosing Spondylitis (AS)
- +2 more
-
Shenzhen, Guangdong, China
- +9 more
Jul 6, 2022
LILRA3 in Ankylosing Spondylitis and Axial Psoriatic Patients
Not yet recruiting
- Autoimmune Diseases
- Leukocyte Immunoglobulin-like receptors A3
- (no location specified)
Jun 14, 2023
Pharmacokinetics, Safety, Efficacy Trial in Dhaka (Advixa (Adalimumab))
Recruiting
- Pharmacokinetics
- +3 more
- Advixa (Adalimumab)
-
Dhaka, BangladeshideSHi
Jul 6, 2022
Participants Receiving Flixabi or Imraldi: a French Cohort Study
Completed
- Arthritis, Rheumatoid
- +4 more
-
Caluire et Cuire, Auvergne-Rhône-Alpes, France
- +59 more
Oct 17, 2022
Subclinical Vertebral Fractures in Rheumatoid Arthritis and
Not yet recruiting
- Vertebral Fracture
- DEXA scan,X_ray
- (no location specified)
Oct 16, 2023
Platelet and Red Blood Cell Volume Indices as Inflammatory
Recruiting
- Ankylosing Spondylitis
- CBC
-
Sohag, EgyptSohag university Hospital
Aug 10, 2023
Temporomandibular Joint Dysfunction in Ankylosing Spondylitis
Completed
- Ankylosing Spondylitis
- Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Axis I and II
-
Istanbul, TurkeyIstanbul Physical Medicine Rehabilitation Training and Research
May 1, 2023
Ankylosing Spondylitis Trial in Usak (Pilates)
Completed
- Ankylosing Spondylitis
- Pilates
-
Usak, Merkez, TurkeyUsak University
Aug 13, 2023
Ankylosing Spondylitis Trial in Shanghai (Jaktinib, Placebo)
Not yet recruiting
- Ankylosing Spondylitis
- Jaktinib
- Placebo
-
Shanghai, Shanghai, ChinaRenJi Hospital
May 6, 2023
Ankylosing Spondylitis Trial in Shanghai (Jaktinib)
Not yet recruiting
- Ankylosing Spondylitis
-
Shanghai, Shanghai, ChinaRenji Hospital
May 6, 2023
Investigate Clinical REsponses in Ankylosing Spondylitis
Completed
- Ankylosing Spondylitis (AS)
-
Hualien City, TaiwanHualien Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation
Nov 18, 2021
Osteoporosis, Osteoporosis Risk, Ankylosing Spondylitis Trial (Patient Participation Form)
Not yet recruiting
- Osteoporosis
- +2 more
- Patient Participation Form
- (no location specified)
Feb 26, 2023
Assess the Efficacy and Safety of Adalloce in RA and AS
Recruiting
- Rheumatoid Arthritis
- Ankylosing Spondylitis
-
Daegu, Korea, Republic ofDaegu Catholic University Medical Center
Apr 18, 2023
Ankylosing Spondylitis (AS) Trial in Wuhan (Secukinumab 300mg s.c., Secukinumab 150mg s.c.)
Recruiting
- Ankylosing Spondylitis (AS)
- Secukinumab 300mg s.c.
- Secukinumab 150mg s.c.
-
Wuhan, Hubei, China
- +2 more
Mar 20, 2022
Ankylosing Spondylitis Trial (Human Umbilical Cord Mesenchymal Stem Cells)
Not yet recruiting
- Ankylosing Spondylitis
- Human Umbilical Cord Mesenchymal Stem Cells
- (no location specified)
Jul 19, 2023
Ankylosing Spondylitis, Aerobic Exercise, Disease Activity Trial in Afyonkarahisar (Aerobic exercises with cycling ergometry,
Recruiting
- Ankylosing Spondylitis
- +2 more
- Aerobic exercises with cycling ergometry
- Stretching exercises
-
Afyonkarahisar, TurkeyAfyonkarahisar Health Sciences University
Jul 27, 2023
Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)
Active, not recruiting
- Spondylitis, Ankylosing
- CC-99677
- Placebo
-
Flagstaff, Arizona
- +139 more
Dec 9, 2022
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction
Completed
- Posterior Tibial Tendon Dysfunction
- +2 more
- Patients with Ankylosing Spondylitis
-
Afyonkarahisar, TurkeyAfyonkarahisar
Sep 27, 2022